Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 2/20 | 0.53 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.51 |
| ▸ | CCR3 | P51677 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CCR1 | P32246 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5846522 | 0.88 | DRD2 (0.56) | SIGMAR1DRD2MEN1LMNAKMT2A | |
| SCHEMBL29284777 | 0.81 | TBXAS1 (0.56) | TBXAS1 | |
| SCHEMBL5846990 | 0.78 | SIGMAR1 (0.59) | SIGMAR1DRD2OPRL1CCR3MEN1 | |
| SCHEMBL29284773 | 0.78 | TBXAS1 (0.52) | TBXAS1 | |
| SCHEMBL5849042 | 0.77 | SIGMAR1 (0.58) | SIGMAR1DRD2OPRL1CCR3MEN1 | |
| SCHEMBL9370237 | 0.76 | SIGMAR1 (0.72) | SIGMAR1DRD2OPRL1CCR3MEN1 | |
| SCHEMBL11062805 | 0.75 | SIGMAR1 (0.70) | SIGMAR1DRD2OPRL1CCR3MEN1 | |
| SCHEMBL11778752 | 0.75 | SIGMAR1 (0.70) | SIGMAR1DRD2OPRL1CCR3MEN1 | |
| SCHEMBL7233756 | 0.75 | SIGMAR1 (0.70) | SIGMAR1DRD2OPRL1CCR3MEN1 | |
| SCHEMBL5847869 | 0.74 | SIGMAR1 (0.54) | SIGMAR1DRD2OPRL1CCR3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE39113-E1 | Utilization of derivatives of tetrahydropyridines(or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain | LABORATORIES DEL DR. ESTEVE, S.A. (ES) | 2006-05-30 | — | — | US | claimed |
| US-6384055-B1 | ANALGESICS | LABORATORIOS DEL DR. ESTEVES, S.A. (ES) | 2002-05-07 | — | — | US | claimed |